Measurement of serum IgG4 levels by an established ELISA system and its clinical applications in autoimmune diseases

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 4, 2013, Pages 611-614

  Sun, Wei ^a   Gao, Rong Fen ^a   Chen, Yu ^a   Su, Yu Ying ^a   Dong, Ling Li ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

autoimmune disease; enzyme linked immunosorbent assay; IgG4; IgG4 related disease

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; AUTOIMMUNE DISEASE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; METHODOLOGY;

AUTOIMMUNE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G;

EID: 84881283880     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1167-y     Document Type: Article

References (13)

1. Divatia M, Kim SA, Ro JY. IgG4-related sclerosing disease, an emerging entity: a review of a multi-system dis ease.Yonsei Med J, 2012,53(1):15-34
2. Ito M, Naruke Y, Mihara Y, et al. Thyroid papillary carcinoma with solid sclerosing change in IgG4-related sclerosing disease. Pathol Int, 2011,61(10):589-592
3. Umehara H. A new clinical entity: IgG4-related disease (IgG4-RD) discovered in the 21st century. Intern Med, 2012,51:821-822
4. Okazaki K, Umehara H. Are classification criteria for IgG4-RD now possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan. Int J Rheumatol, 2012,2012:357071
5. Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis. J Gastroenterol Hepatol, 2009,24(1):15-36
6. Stone J H, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum, 2012,64(10):3061-3067
7. Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum, 2010,62(6):1755-1762
8. Khosroshahi A, Carruthers MN, Deshpande V, et al. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore), 2012,91(1):57-66
9. Tabata T, Kamisawa T, Takuma K, et al. Serial changes of elevated serum IgG4 levels in IgG4-related systemic disease. Intern Med, 2011,50:69-75
10. Masaki Y, Kurose N, Yamamoto M, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol, 2012,2012:580814
11. Yamamoto M, Tabeya T, Naishiro Y, et al. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol, 2012,22(3):419-25
12. Ebbo M, Grados A, Bernit E, et al. Pathologies associated with serum IgG4 elevation. Int J Rheumatol, 2012,2012: 602809
13. Stone JH, Zen Y, Deshpande V, et al. IgG4-related disease. N Engl J Med, 2012,366:1643-1647